Publications for Elisabeth Skogh
Co-author map based on ISI articles 2007-

Publications mentioned in social media 4 times*

Journal Articles

Mao Mao, Elisabeth Skogh, Maria Gabriella Scordo and Marja-Liisa Dahl
  Letter: Interindividual Variation in Olanzapine Concentration Influenced by UGT1A4 L48V Polymorphism in Serum and Upstream FMO Polymorphisms in Cerebrospinal Fluid
 
Altmetric usage: 3

  Journal of Clinical Psychopharmacology, 2012, 32(2), 287-289.

Klas R Linderholm, Elisabeth Skogh, Sara K Olsson, Marja-Liisa Dahl, Maria Holtze, Göran Engberg, Martin Samuelsson and Sophie Erhardt
  Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
  Schizophrenia Bulletin, 2012, 38(3), 426-432.
 Web of Science® Times Cited: 8

Elisabeth Skogh, Ingemar Sjödin, Martin Josefsson and Marja-Liisa Dahl
  High Correlation Between Serum and Cerebrospinal Fluid Olanzapine Concentrations in Patients With Schizophrenia or Schizoaffective Disorder Medicating With Oral Olanzapine as the Only Antipsychotic Drug
 
Altmetric usage: 1

  Journal of Clinical Psychopharmacology, 2011, 31(1), 4-9.
 Web of Science® Times Cited: 6

Martin Josefsson, Markus Roman, Elisabeth Skogh and Marja-Liisa Dahl
  Liquid chromatography/tandem mass spectrometry method for determination of olanzapine and N-desmethylolanzapine in human serum and cerebrospinal fluid
  Journal of Pharmaceutical and Biomedical Analysis, 2010, 53(3), 576-582.
 Web of Science® Times Cited: 11

Linda K Nilsson-Todd, Conny Nordin, Erik G Jönsson, Elisabeth Skogh and Sophie Erhardt
  Cerebrospinal fluid kynurenic acid in male patients with schizophrenia - Correlation with monoamine metabolites
  Acta Neuropsychiatrica, 2007, 19(1), 45-52.
 Web of Science® Times Cited: 2

Elisabeth Skogh, Margareta Reis, Marja-Liisa Dahl, Jöns Lundmark and Finn Bengtsson
  Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting
  Therapeutic Drug Monitoring, 2002, 24(4), 518-526.
 Web of Science® Times Cited: 52

Sophie Erhardt, Kaj Blennow, Conny Nordin, Elisabeth Skogh, Leif Lindström and Göran Engberg
  Kynurenic acid levels ae elevated in the cerebrospinal fluid of patients with schizophrenia
  Neuroscience Letters, 2001, 313(1-2), 96-98.
 Web of Science® Times Cited: 126

Elisabeth Skogh, Finn Bengtsson and Conny Nordin
  Could discontinuing smoking be hazardous for patients administered clozapine medication? A case report.
  Therapeutic Drug Monitoring, 1999, 21, 580-582.

Conference Articles

Elisabeth Skogh, Ingemar Sjödin, Martin Josefsson and M.L. Dahl
  Olanzapine in serum and cerebrospinal fluid in patients with schizophrenia or schizoaffective disorder in EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol 20, issue , pp S469-S469
  EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010.


Licentiate Theses

Elisabeth Skogh
  Studies on Variability in Olanzapine Disposition
  2011.


  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.